Morphea - 硬斑病https://en.wikipedia.org/wiki/Morphea
硬斑病 (Morphea) 是硬皮病的一种,可使面部、手部、脚部或身体其他部位的皮肤变硬,但不累及内脏器官。硬斑病是由于胶原蛋白过度沉积导致皮肤和皮下组织增厚、硬化。硬斑病与“系统性硬化症”的区别在于不涉及内脏器官。

硬斑病是一种非常罕见的疾病。由于照片的构图,算法可能会误将其识别为硬斑病 (Morphea)。

☆ 德国 Stiftung Warentest 2022 年的结果显示,消费者对 ModelDerm 的满意度仅略低于付费远程医疗咨询。
  • 硬斑病 (Morphea) 的病变通常表现为萎缩性色素斑块。
  • Frontal linear scleroderma
  • Frontal linear scleroderma
  • 变薄(或褪色)的黑白色病变可提示硬斑病 (Morphea)。
References Localized scleroderma: clinical spectrum and therapeutic update 25672301 
NIH
Scleroderma 是一种影响结缔组织的罕见疾病,表现为皮肤硬化,有时会波及身体的其他部位。主要有两种类型:systemic sclerosis(系统性硬皮病),涉及皮肤硬化和内脏器官;localized scleroderma(局限性硬皮病),亦称硬斑病,通常仅限于皮肤及其下方组织,病程良性且自限。尽管局限性硬皮病(localized scleroderma)并不常见,病因尚不明确,但最近的研究表明,它也可能影响内脏器官并导致各种健康问题。鉴于局限性硬皮病(localized scleroderma)潜在的严重性,早期治疗对于预防并发症至关重要。
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
 Upcoming treatments for morphea 34272836 
NIH
Morphea,也称为局限性硬皮病,是一种影响结缔组织的罕见自身免疫性疾病。它可呈多种形式出现,发病率并不高,每年每10万人中约有0.4‑2.7例。Morphea 常见于2至14岁的儿童,且女孩比男孩更易受影响。
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.